当前位置: X-MOL 学术JAMA Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Semaglutide Eligibility Across All Current Indications for US Adults
JAMA Cardiology ( IF 14.8 ) Pub Date : 2024-11-18 , DOI: 10.1001/jamacardio.2024.4657
Ivy Shi, Sadiya S. Khan, Robert W. Yeh, Jennifer E. Ho, Issa J. Dahabreh, Dhruv S. Kazi

This cross-sectional study uses National Health and Nutrition Examination Survey data to examine the number of US adults eligible for semaglutide across all current indications.

中文翻译:


Semaglutide 适用于美国成人的所有当前适应症



这项横断面研究使用全国健康和营养检查调查数据来检查在所有当前适应症中符合 semaglutide 条件的美国成年人人数。
更新日期:2024-11-18
down
wechat
bug